Lv21
110 积分 2023-09-19 加入
Organoids in biliary tract cancers: Advances in modeling strategies and translational applications
1小时前
待确认
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
12天前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
14天前
已完结
Machine learning models for predicting chemotherapy-induced adverse drug reactions in colorectal cancer patients
1个月前
已完结
Rapid Characterization of the Constituents in Classic Chinese Medicine Formula Guyinjian Using Ultra‐High‐Performance Liquid Chromatography With Quadrupole Time‐of‐Flight Mass Spectrometry
1个月前
已完结
Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations
2个月前
已完结
Is There Still Room for Monotherapy in EGFR-Mutated Non-Small Cell Lung Cancer?
2个月前
已完结
Perioperative serplulimab with neoadjuvant chemotherapy versus perioperative chemotherapy in PD-L1-positive gastric cancer (ASTRUM-006): a randomised, double-blind, multicentre, phase 3 study
2个月前
已完结
Novel strategies to overcome the blood–brain barrier in triple-negative breast cancer brain metastases
2个月前
已完结